Composition comprising immunogenic nanoparticles

Details for Australian Patent Application No. 2006204620 (hide)

International Classifications

Event Publications

14 September 2006 Complete Application Filed

28 September 2006 Application Open to Public Inspection

Published as AU-B-2006204620

29 May 2008 Application Accepted

Published as AU-B-2006204620

30 October 2008 Assignment before Grant

The Austin Research Institute The application has been assigned to The Macfarlane Burnet Institute for Medical Research and Public Health Ltd

4 December 2008 Standard Patent Sealed

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 October 2012 Section 223 Application Received

The Macfarlane Burnet Institute for Medical Research and Public Health Ltd An application to extend the time from 14 Sep 2011 to 14 Aug 2012 in which to pay a renewal fee has been filed . Address for service in Australia - King & Wood Mallesons Level 50 Bourke Place 600 Bourke Street Melbourne VIC 3000 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.